Immunohistochemical studies have classified breast cancer into four broad subtypes: oestrogen receptor-positive (ER+), progesterone receptor-positive (PR+), human epidermal growth factor receptor 2-positive (HER2+) and triple negative [1]. This evidence concerns the gene ERBB2 and breast cancer.